Analyst Ratings for Ligand Pharma (LGND)
LGND Rating Summary
LGND Price Target Summary
- Highest: $388.00 (BofA Securities)
- Lowest: $289.00 (H.C. Wainwright)
- Average: $340.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$340.22 (+19.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/14/2026 | Leerink | David Risinger | New Coverage | Outperform (N/A) |
330.00 (N/A) |
288.82 (284.27) |
-1.58% | Details |
| 7/21/2026 | Citi | Yigal Nochomovitz | New Coverage | Buy (N/A) |
387.00 (N/A) |
293.99 (284.27) |
-3.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
